CYTOKINETICS, INCORPORATED Class of Warrant or Right, Outstanding
CYTOKINETICS, INCORPORATED (CYTK) had Class of Warrant or Right, Outstanding of 12.96 thousand shares as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2024-02-28
- 2023-12-31: Class of Warrant or Right, Outstanding 12.96K shares.
- 2021-12-31: Class of Warrant or Right, Outstanding 165.42K shares.
- 2020-12-31: Class of Warrant or Right, Outstanding 165.42K shares.
- 2019-12-31: Class of Warrant or Right, Outstanding 165.42K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2023-12-31 | 12.96K shares 10-K · filed 2024-02-28 |
| 2021-12-31 | 165.42K shares 10-K · filed 2022-02-25 |
| 2020-12-31 | 165.42K shares 10-K · filed 2021-02-26 |
| 2019-12-31 | 165.42K shares 10-K · filed 2020-03-04 |
| 2019-03-31 | 142.36K shares 10-Q · filed 2019-05-09 |
| 2018-12-31 | 142.36K shares 10-K · filed 2019-03-07 |
| 2018-09-30 | 142.36K shares 10-Q · filed 2018-11-09 |
| 2018-06-30 | 100.11K shares 10-Q · filed 2018-08-07 |
| 2018-03-31 | 100.11K shares 10-Q · filed 2018-05-10 |
| 2017-12-31 | 100.11K shares 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |